American Lung Association Celebrates Effective Treatment Option for Latent TB Infection

Washington, D.C. (May 17, 2011)

As an organization founded in 1904 to combat tuberculosis (TB), the American Lung Association is encouraged by results of the Centers for Disease Control and Prevention’s (CDC) clinical trials on effective treatment of latent TB infection.

This is an important study and is directly applicable to the care of patients with latent TB in the US.  A major obstacle to preventive treatment among patients with TB has been a lack of adherence to the nine months of treatment. Implementation of this three-month regimen should significantly increase the number of patients receiving full treatment, thus decreasing the number of activations of the disease in the years to come.

For additional information on Tuberculosis, visit the American Lung Association website.


About the American Lung Association
Now in its second century, the American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease. With your generous support, the American Lung Association is “Fighting for Air” through research, education and advocacy. For more information about the American Lung Association, a Charity Navigator Four Star Charity and holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNG-USA (1-800-586-4872) or visit